¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Amino Acid Transport Systems"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast organism
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
  • acid-fastness
    Ç׻꼺
  • adenylic acid
    ¾Æµ¥´Ò»ê
  • allokainic acid
    ¾Ë·ÎÄ«Àλê
  • aminohippuric acid
    ¾Æ¹Ì³ëÈ÷Ǫ¸£»ê
  • benzoic acid
    º¥Á¶»ê
  • bile acid
    ´ãÁó»ê
  • boric acid
    ºØ»ê
  • boric acid ointment
    ºØ»ê¿¬°í
  • boric acid poisoning
    ºØ»êÁßµ¶
  • butyric acid
    ºÎƼ¸£»ê
  • cacodylic acid
    Ä«ÄÚµô»ê
  • citric acid
    ½ÃÆ®¸£»ê, ±¸¿¬»ê
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acid radical
    »ê±â
  • acid salt
    »ê¼º¿°
  • acid-fast stain
    Ç׻꿰»ö
  • acetylsalycylic acid antiplatelet therapy
    Ç×Ç÷¼ÒÆÇ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acid-base compensation
    »ê¿°±âº¸»ó
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • acid-base indicator
    »ê¿°±âÇ¥Áö½Ã°è
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
  • allokainic acid
    ¾Ë·ÎÄ«Àλê
  • aminohippuric acid
    ¾Æ¹Ì³ë¸¶´¢»ê
  • anthranilic acid
    ¾ÈÆ®¶ó´Ò»ê
  • arachidonic acid
    ¾Æ¶ó۵·»ê
  • arsenic acid
    ºñ»ê
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê
  • benzoic acid
    º¥Á¶»ê
  • bile acid
    ´ãÁó»ê
  • boric acid
    ºØ»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • GABA=£¾gamma aminobutylic acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê(ß«).
  • Gamma-aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê(ß«)
  • Glycogen-lactic acid system
    ±Û¸®ÄÚ°Õ-¶ôÆ®»ê°è
  • Growth folic acid in
    ¼ºÀå(à÷íþ)¿°»ê(ç¤ß«)¿°
  • HIAA = 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·ÎÀε¹ÃÊ»ê
  • Hydrochloric acid
    ÇÏÀ̵å·ÎÅ©·Ð»ê
  • Hydroxybutyric acid
    ÇÏÀ̵å·ÎºÎÆ¿»ê
  • Lactic acid = lactate
    ¶ôÆ®»ê(¡­ß«),Á¥»ê(¡­ß«)
  • Lactic acid dehydrogenase
    ¶ôÆ® »êÅ»¼ö¼ÒÈ¿¼Ò(¡­ß«÷­â©áÈý£áÈ)
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p- ¾Æ¹Ì³ë¾È½ÄÇâ»ê
  • N-Formiminoglutamic acid
    N-Æ÷¸§À̹̳ë±Û·çŽ»ê
  • RNA =>ribonucleic acid
    ¸®º¸ÇÙ»ê
  • RNA=£¾ribonucleic acid
    ¸®º¸ÇÙ»ê.
  • VMA =>vanillymandelic acid
    ¹Ù´Ò¸¸µ¥¸¯»ê
  • abietolic acid
    ¾Æºñ¿¡Åç»ê.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • facilitated transport
    ÃËÁø¼ö¼Û(¡­âÃáê).
  • gas transport
    °¡½º¿î¹Ý(ê¡Úæ).
  • glucose transport protein unit
    Æ÷µµ´ç ¿î¹Ý ´Ü¹é ´ÜÀ§(GLUT)
  • lipid transport
    ÁöÁú¿î¼Û
  • medium, transport
    ¼ö¼Û¹èÁö
  • membrane transport
    ¼¼Æ÷¸·À» ÅëÇÑ À̵¿.
  • net transport
    ¼ø¿î¹Ý.
  • oxygen transport
    »ê¼Ò¿î¹Ý(¡­¿î¹Ý).
  • oxygen transport
    »ê¼Ò¿î¹Ý(¡­ê¡Úæ).
  • oxygen transport mechanism
    »ê¼Ò¿î¹Ý ±âÀü.
  • passive transport
    Çǵ¿Àû ¿î¹Ý(¡­ê¡Úæ).
  • piece, transport
    ¿î¹Ý¼ººÐ, ¼ö¼Û¼ººÐ
  • plasma membrane carnitine transport defect
  • sodium transport system
    ³ªÆ®·ý¿î¹Ý°è (¡­ê¡ÚæÍ§).
  • specimen transport
    °Ëü¼ö¼Û
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mixed amino acid fermentation
    È¥ÇÕ(ûèùê)¾Æ¹Ì³ë»ê¹ßÈ¿(Û£ý£)
  • neutral amino acid
    Áß¼º(ñéàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nonpolar amino acid
    ¹«±Ø¼º(Ùíпàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nonprotein amino acid
    ºñ´Ü¹éÁú(ÞªÓ±ÛÜòõ) ¾Æ¹Ì³ë»ê(ß«)
  • phenylthiocarbamyl amino acid
    Æä´ÒƼ¿ÀÄ«¸£¹Ù¹Ð¾Æ¹Ì³ë»ê(ß«)
  • phenylthiohydantoin amino acid
    Æä´ÒƼ¿ÀÇÏÀÌ´ÜÅäÀξƹ̳ë»ê(ß«)
  • polar amino acid
    ±Ø¼º(пàõ) ¾Æ¹Ì³ë»ê(ß«)
  • primary amino acid
    ÀÏÂ÷(ìéó­) ¾Æ¹Ì³ë»ê(ß«)
  • PTC-amino acid
    PTC ¾Æ¹Ì³ë»ê(ß«)
  • PTH-amino acid
    PTH ¾Æ¹Ì³ë»ê(ß«)
  • radical amino acid replacement
    ¶óµðÄ® ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
  • rare amino acid
    Èñ±Í(ýüÏþ) ¾Æ¹Ì³ë»ê
  • sulfur amino acid
    Ȳ(üÜ)¾Æ¹Ì³ë»ê(ß«)
  • uncharged polar amino acid
    ¹«ÀüÇÏ(Ùíï³ùÃ) ±Ø¼º(пàõ)¾Æ¹Ì³ë»ê(ß«)
  • uncoded amino acid
    ¹«(Ùí)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BCAA Branched Chain Amino Acid
¥â-ABA ¥â-Amino-Butyric Acid
Bz-Ty-PABA test N-Benzoyl-L-Tyrosyl-p-Amino-Benzoic Acid test
  = Bentiromide test
  = Tr...
¥ä-ALA ¥ä-Amino-Levulinic Acid
¥ä-ALAD ¥ä-Amino-Levulinic Acid Dehydratase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CT counter transport
ETS electron transport system
TR transport rate
aa 212-amino-acid
AIB 14C-amino isobutyric acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acid mucopolysaccharide
    »ê¼º Á¡¾× ´Ù´ç·ù
  • acid phosphatase assay
    »ê¼º Æ÷½ºÆÄŸÁ¦ ÃøÁ¤
  • acid radical
    »ê±â
    À¯±â, ¹«±âÀÇ °¢Á¾ »êÀÇ ºÐÀڷκÎÅÍ ¼ö¼Ò ÀÌ¿ÂÀ¸·Î¼­ ÀÌ¿ÂÈ­ ÇÒ ¼ö ÀÖ´Â ¼ö¼Ò ¿øÀÚ¸¦ ÇÑ °³ ÀÌ»ó ¶¼¾î ³½ ³ª¸ÓÁö ¿øÀÚ ¶Ç´Â ¿øÀÚ´Ü.
  • acid spring
    »ê¼º õ
    ¹° 1kg ¼Ó¿¡ ¼ö¼ÒÀ̿ 1mg ÀÌ»óÀ» ÇÔÀ¯Çϸç À½À̿°ú Á¶ÇÕ½ÃŰ¸é ¿°»êÀ̳ª Ȳ»ê°ú °°Àº À¯¸® ±¤»êÀ» ±¸¼ºÇÑ´Ù. ÀϺ» µî È­»êÀÌ ¸¹Àº ³ª¶óÀÇ Æ¯À¯ÇÑ ¿ÂõÀ̸ç, ºÐÈ­±¸, ºÐ±â°ø ±Ùó¿¡¼­ ¼Ú¾Æ ³ª¿À´Â ÀÏÀÌ ¸¹°í, ÀϹÝÀûÀ¸·Î °í¿ÂÀÌ´Ù. Ȳȭ¼ö¼Ò, ¸í¹Ý, ³ì¹Ý µîÀ» µ¿½Ã¿¡ ÇÔÀ¯Çϰí ÀÖ´Ù. ÇǺÎÀÇ ÀÚ±ØÀÌ °­Çϰí Áþ¹«¸§ÀÌ ÀϾ±â ½¬¿ì¹Ç·Î ÇǺο°¿¡ ÁÖÀÇÇÑ´Ù.
  • acid tide
    »êÁõ°¡±â
    ÀϽÃÀûÀ¸·Î ¿äÀÇ »êµµ°¡ Áõ°¡ÇÏ´Â Çö»ó.
  • acid value
    »ê°ª, »ê°¡
    À¯Áö 1g¿¡ ÇÔÀ¯µÈ À¯¸® Áö¹æ»êÀ» ÁßÈ­Çϴµ¥ ÇÊ¿äÇÑ ¼ö»êÈ­Ä®·ýÀÇ §·¼ö¸¦ »ê°¡¶ó ÇÑ´Ù. À¯Áö´Â ¿À·¡ µÇ¸é À¯¸® Áö¹æ»êÀÌ Áõ°¡ÇϹǷΠ½Å¼±µµ µîÀÇ ±âÁØÀÌ µÈ´Ù. ½Ä¿ëÀ¯Áö´Â »ê°¡ 1 ÀÌÇÏÀÇ °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù°í ÇÑ´Ù.
  • acid-base
    »ê ¿°±â
  • acid-base balance disturbance
    »ê ¿°±â ÆòÇü ÀÌ»ó
    »ê°ú ¿°±âÀÇ ÆòÇüÀÌ ±úÁø »óÅÂ.
  • acid-base compensation
    »ê ¿°±â º¸»ó
  • acid-base indicator
    »ê ¿°±â Áö½Ã¾à
  • acid-fast nonmotile rod
    Ç׻꼺 ºñ¿îµ¿¼º °£±Õ
  • acid-gel application
    °ÖÇü »ê Àû¿ë
  • adenylic acid deaminase
    ¾Æµ¥´Ò»ê Å»¾Æ¹Ì³ë È¿¼Ò
  • aldobionic acid
    ¾Ëµµºñ¿Â»ê
    C11H19O10COOH. ±× ¼ººÐ´çÀÇ Çϳª·Î¼­ ¿ì·Ð»êÀ» ÇÔÀ¯Çϰí ÀÖ´Â ÀÌ´ç·ùÀ̸ç, ¿©·¯ Á¾·ùÀÇ ½Ä¹°¼º °í¹«¿Í ƯÁ¤ÇÑ º´¿øÃ¼ Áß¿¡ Á¸ÀçÇÑ´Ù. Æó·Å±Õ 3ÇüÀÇ Æ¯¼ö ´Ù´ç·ùÀÇ °¡¼öºÐÇØ¿¡ ÀÇÇØ¼­ ¾òÀ» ¼ö ÀÖ´Ù.
  • allokainic acid
    ¾Ë·ÎÄ«ÀÎ »ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
excitatory amino acid antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
(12 Dec 1998)
1-carbamoyl-L-amino acid amidohydrolase <enzyme> From bacillus stearothermophilus; amino acid sequence given in first source
Registry number: EC 3.5.1.-
Synonym: carbamoyl l-aa amidohydrolase, n-carbamyl-l-amino acid amidohydrolase
(26 Jun 1999)
adverse drug reaction reporting systems Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.
(12 Dec 1998)
ambulatory care information systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of ambulatory care services and facilities.
(12 Dec 1998)
animal identification systems Procedures for recognizing individual animals and certain identifiable characteristics pertaining to them; includes computerised methods, ear tags, etc.
(12 Dec 1998)
radiology information systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of radiology services and facilities.
(12 Dec 1998)
management information systems Systems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc.
(12 Dec 1998)
man-machine systems A system in which the functions of the man and the machine are interrelated and necessary for the operation of the system.
(12 Dec 1998)
patient identification systems Organised procedures for establishing patient identity, including use of bracelets, etc.
(12 Dec 1998)
medical records systems, computerised Computer-based systems for input, storage, display, retrieval, and printing of information contained in a patient's medical record.
(12 Dec 1998)
medication systems Overall systems, traditional or automated, to provide medication to patients.
(12 Dec 1998)
medication systems, hospital Overall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician's order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient.
(12 Dec 1998)
personnel staffing and scheduling information systems Computer-based systems for use in personnel management in a facility, e.g., distribution of caregivers with relation to patient needs.
(12 Dec 1998)
clinical laboratory information systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative and clinical activities associated with the provision and utilization of clinical laboratory services.
(12 Dec 1998)
clinical pharmacy information systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of clinical pharmacy services.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • glutamic acid
    ±Û·çŸ¹Î»ê
  • hyaluronic acid
    È÷¾Ë·ç·Ð»ê (»ê¼º´ç·ù)
  • hydriodic acid
    ¿ÁÈ­ ¼ö¼Ò»ê
  • hydrochloric acid
    ¿°»ê
  • hydrocyanic acid
    ½Ã¾ÈÈ­ ¼ö¼Ò»ê;û»ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
  • hypochlorous acid
    Â÷¾Æ¿°¼Ò»ê
  • hypophosphoric acid
    Â÷Àλê
  • hypophosphorous acid
    Â÷¾ÆÀλê
  • indoleacetic acid
    Àε¹ÃÊ»ê(½Ä¹°ÀÇ ¼ºÀå È£¸£¸ó)
  • inosinic acid
    À̳ë½Å»ê
  • iodic acid
    ¿ä¿Àµå»ê
  • isonicotinic acid hydrazide
    (¾à)À̼ҴÏÄÚÆ¾»ê ÇÏÀ̵å¶óÁöµå(°áÇÙ Ä¡·áÁ¦)
  • lactic acid
    À¯»ê
  • maleci acid
    ¸»·¹»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á